Thomas A. McCourt
2012
In 2012, Thomas A. McCourt earned a total compensation of $1.2M as Senior Vice President, Marketing and Sales and Chief Commercial Officer at Ironwood Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $111,668 |
|---|---|
| Option Awards | $699,409 |
| Salary | $354,500 |
| Other | $7,440 |
| Total | $1,173,017 |
McCourt received $699.4K in option awards, accounting for 60% of the total pay in 2012.
McCourt also received $111.7K in non-equity incentive plan, $354.5K in salary and $7.4K in other compensation.
Rankings
In 2012, Thomas A. McCourt's compensation ranked 5,513th out of 11,487 executives tracked by ExecPay. In other words, McCourt earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,513 out of 11,487 | 52nd |
Division Manufacturing | 1,942 out of 4,253 | 54th |
Major group Chemicals And Allied Products | 470 out of 1,198 | 61st |
Industry group Drugs | 312 out of 920 | 66th |
Industry Pharmaceutical Preparations | 243 out of 700 | 65th |
Source: SEC filing on April 17, 2015.
McCourt's colleagues
We found three more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2012.
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019